Completed PHASE3 INTERVENTIONAL 2-arm NCT01874717

Midazolam Sedation in Dentally Anxious Patients

Conscious Sedation With Midazolam in Dentally Anxious Patients: Effect of the Administration Route (Oral Versus Intravenous Administration)

Sponsor: University Hospital, Clermont-Ferrand

Conditions Dental Anxiety

Interventions Conscious sedation for dental care midazolam

Updated 5 times since 2017 Last updated: Jun 10, 2013 Started: Jun 30, 2005 Primary completion: Aug 31, 2007 Completion: Aug 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01874717, this PHASE3 trial focuses on Dental Anxiety and remains completed. Sponsored by University Hospital, Clermont-Ferrand, it has been updated 5 times since 2005, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Clermont-Ferrand

Data source: University Hospital, Clermont-Ferrand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clermont-Ferrand, France